The Novavax vaccine had 90% efficacy against COVID-19 ≥7 d after the second dose.
Where this comes from
- Record sourced from PubMed, PMID 34724399.
- Also identified by DOI 10.7326/ACPJ202111160-124.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Heath PT, Galiza EP, Baxter DN, et al. <b>Safety and efficacy of NVX-CoV2373 Covid-19 vaccine.</b> N Engl J Med. 2021;385:1172-83. 34192426.
Medical subject headings
- COVID-19
- Vaccines